Elevated ALS Biomarker Levels in CSF of a FTD Patient at the Presymptomatic Stage of ALS

Alzheimer Dis Assoc Disord. 2018 Apr-Jun;32(2):156-157. doi: 10.1097/WAD.0000000000000222.

Authors

Emmanuel Cognat^{1

2}, Maxim De Schaepdryver³, Jacques Hugon^{1

2

4}, Koen Poesen³, Claire Paquet^{1

2

4}

Affiliations

¹ Cognitive Neurology Center AP-HP, GH Saint-Louis Lariboisière Fernand-Widal.
² INSERM, U942.
³ Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, KU Leuven (University of Leuven) and Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
⁴ University Paris Diderot, Sorbonne Paris Cité, Paris, France.

PMID: 29189300
DOI: 10.1097/WAD.0000000000000222

No abstract available

MeSH terms

Amyotrophic Lateral Sclerosis / cerebrospinal fluid*
Biomarkers / cerebrospinal fluid*
Frontotemporal Lobar Degeneration / cerebrospinal fluid*
Humans
Male
Middle Aged

Substances

Biomarkers